| è´§å· | å“牌 | 产å“åç§° | è§„æ ¼ | 包装ã€å‚è€ƒä»·æ ¼ | |
| A800687 | MACKLIN | è…ºå˜Œå‘¤æ ¸è‹·(腺苷) | 分æžå¯¹ç…§å“, 99.8% | 179å…ƒ/20mg; | 咨询 |
储å˜ï¼š2~8°C 状æ€ï¼šç™½è‰²åˆ°å‡ 乎白色粉末到晶体 è…ºè‹·æ˜¯ä»¥æ ¸è‹·å’Œå˜Œå‘¤ä¸ºåŸºæœ¬æž„é€ çš„æ´»æ€§ç‰©è´¨ï¼Œæ˜¯ç”±è…ºå˜Œå‘¤é€šè¿‡β-糖苷键结åˆD-æ ¸ç³–å½¢æˆçš„ä¸€ç§æ ¸è‹·ï¼Œå®ƒå¹¿æ³›åœ°å˜åœ¨äºŽæ‰€æœ‰ç±»åž‹çš„细胞ä¸ï¼Œåœ¨æ ¸é…¸ä¸æ—¢å¯æ˜¯æ¸¸ç¦»çš„ä¹Ÿå¯æ˜¯åŒ–åˆçš„æ ¸è‹·ã€‚åƒATPè¿™æ ·çš„è…ºè‹·ç£·é…¸é…¯æ˜¯ç”Ÿç‰©åŒ–å¦å应ä¸é‡è¦çš„能é‡è½½ä½“ã€‚è…ºè‹·ä¸ºä¸€å¤©ç„¶æ ¸è‹·é…¸ï¼Œæ˜¯æœºä½“ä»£è°¢çš„ä¸é—´äº§ç‰©ï¼Œä¹Ÿæ˜¯ä½“内é‡è¦æ´»æ€§æˆåˆ†ä¹‹ä¸€ã€‚其作用系通过激活腺苷å—体(Aå—体)而实现。在心房ã€çª¦æˆ¿ç»“åŠæˆ¿å®¤ç»“,腺苷通过与Aå—体结åˆè€Œæ¿€æ´»G蛋白å¶è”的钾通é“,使K+外æµå¢žåŠ ï¼Œç»†èƒžè†œè¶…æžåŒ–而é™ä½Žè‡ªå¾‹æ€§ã€‚å®ƒè¿˜èƒ½æ˜Žæ˜¾å¢žåŠ cGMP水平,延长房室结的ERPå’Œå‡æ…¢ä¼ å¯¼ï¼ŒæŠ‘åˆ¶äº¤æ„Ÿç¥žç»æˆ–å¼‚ä¸™è‚¾ä¸Šè…ºç´ æ‰€è‡´æ—©åŽã€è¿ŸåŽé™¤æžè€Œå‘æŒ¥æŠ—å¿ƒå¾‹å¤±å¸¸ä½œç”¨ã€‚æœ¬å“æš‚æœªè¢«åˆ†ç±»äºŽâ… ~Ⅳ类抗心律失常è¯ä¸ã€‚è…ºè‹·æ˜¯ä¸æž¢ç¥žç»ç³»ç»Ÿçš„ä¸€ç§æŠ‘åˆ¶æ€§ç¥žç»è°ƒè´¨ï¼Œå¯åœ¨å¤§è„‘的能é‡å‚¨å˜åŠèƒ½é‡éœ€æ±‚之间æä¾›ä¿¡å·ï¼Œä½¿ä¹‹è¾¾åˆ°ä¸€ç§å¹³è¡¡ã€‚在æ£å¸¸æƒ…况下,细胞外腺苷浓度维æŒåœ¨40~400nmoL。当缺血缺氧时,葡è„糖和糖原å‡åŠ é€Ÿåˆ†è§£äº§ç”ŸATP以应能é‡éœ€æ±‚,ATP继而é™è§£ï¼Œä½¿ç»†èƒžå†…腺苷水平急剧å‡é«˜ï¼Œå¹¶é‡Šæ”¾åˆ°ç»†èƒžå¤–呿Œ¥å…¶è°ƒèŠ‚ä½œç”¨ã€‚åœ¨ç¼ºæ°§æ¢å¤é˜¶æ®µï¼Œå†…æºæ€§è…ºè‹·ä½œä¸ºATPåˆæˆçš„å‰ä½“,在腺苷激酶(AK)的催化下å¯å†ç”ŸæˆATPï¼Œä»¥å»¶é•¿ç»†èƒžçš„ç”Ÿå˜æ—¶é—´ã€‚è…ºè‹·æœ‰æ‰©å¼ å† çŠ¶åŠ¨è„‰è¡€ç®¡å’Œå‡ä½Žå¿ƒè‚Œæ”¶ç¼©åŠ›çš„ä½œç”¨ã€‚ä¸´åºŠä¸Šé€‚ç”¨äºŽæ²»ç–—å¿ƒç»žç—›ã€é«˜è¡€åŽ‹ã€è„‘血管障ç¢ã€ä¸é£ŽåŽé—ç—‡ã€è¿›è¡Œæ€§è‚ŒèŽç¼©ç—‡ç‰ã€‚陿³¨ç”¨äºŽæ²»ç–—室上性心动过速åŠ201Tl心肌显åƒã€‚ |
| A800688 | MACKLIN | è…ºå˜Œå‘¤æ ¸è‹· | 超纯级,99.5% | 29å…ƒ/1g; 59å…ƒ/5g; 130å…ƒ/25g; 357å…ƒ/100g; 1299å…ƒ/500g; 3666å…ƒ/2.5kg; | 咨询 |
储å˜ï¼š2~8°C 状æ€ï¼šç™½è‰²ç²‰æœ«æˆ–晶体 è…ºè‹·æ˜¯ä»¥æ ¸è‹·å’Œå˜Œå‘¤ä¸ºåŸºæœ¬æž„é€ çš„æ´»æ€§ç‰©è´¨ï¼Œæ˜¯ç”±è…ºå˜Œå‘¤é€šè¿‡β-糖苷键结åˆD-æ ¸ç³–å½¢æˆçš„ä¸€ç§æ ¸è‹·ï¼Œå®ƒå¹¿æ³›åœ°å˜åœ¨äºŽæ‰€æœ‰ç±»åž‹çš„细胞ä¸ï¼Œåœ¨æ ¸é…¸ä¸æ—¢å¯æ˜¯æ¸¸ç¦»çš„ä¹Ÿå¯æ˜¯åŒ–åˆçš„æ ¸è‹·ã€‚åƒATPè¿™æ ·çš„è…ºè‹·ç£·é…¸é…¯æ˜¯ç”Ÿç‰©åŒ–å¦å应ä¸é‡è¦çš„能é‡è½½ä½“ã€‚è…ºè‹·ä¸ºä¸€å¤©ç„¶æ ¸è‹·é…¸ï¼Œæ˜¯æœºä½“ä»£è°¢çš„ä¸é—´äº§ç‰©ï¼Œä¹Ÿæ˜¯ä½“内é‡è¦æ´»æ€§æˆåˆ†ä¹‹ä¸€ã€‚其作用系通过激活腺苷å—体(Aå—体)而实现。在心房ã€çª¦æˆ¿ç»“åŠæˆ¿å®¤ç»“,腺苷通过与Aå—体结åˆè€Œæ¿€æ´»G蛋白å¶è”的钾通é“,使K+外æµå¢žåŠ ï¼Œç»†èƒžè†œè¶…æžåŒ–而é™ä½Žè‡ªå¾‹æ€§ã€‚å®ƒè¿˜èƒ½æ˜Žæ˜¾å¢žåŠ cGMP水平,延长房室结的ERPå’Œå‡æ…¢ä¼ å¯¼ï¼ŒæŠ‘åˆ¶äº¤æ„Ÿç¥žç»æˆ–å¼‚ä¸™è‚¾ä¸Šè…ºç´ æ‰€è‡´æ—©åŽã€è¿ŸåŽé™¤æžè€Œå‘æŒ¥æŠ—å¿ƒå¾‹å¤±å¸¸ä½œç”¨ã€‚æœ¬å“æš‚æœªè¢«åˆ†ç±»äºŽâ… ~Ⅳ类抗心律失常è¯ä¸ã€‚è…ºè‹·æ˜¯ä¸æž¢ç¥žç»ç³»ç»Ÿçš„ä¸€ç§æŠ‘åˆ¶æ€§ç¥žç»è°ƒè´¨ï¼Œå¯åœ¨å¤§è„‘的能é‡å‚¨å˜åŠèƒ½é‡éœ€æ±‚之间æä¾›ä¿¡å·ï¼Œä½¿ä¹‹è¾¾åˆ°ä¸€ç§å¹³è¡¡ã€‚在æ£å¸¸æƒ…况下,细胞外腺苷浓度维æŒåœ¨40~400nmoL。当缺血缺氧时,葡è„糖和糖原å‡åŠ é€Ÿåˆ†è§£äº§ç”ŸATP以应能é‡éœ€æ±‚,ATP继而é™è§£ï¼Œä½¿ç»†èƒžå†…腺苷水平急剧å‡é«˜ï¼Œå¹¶é‡Šæ”¾åˆ°ç»†èƒžå¤–呿Œ¥å…¶è°ƒèŠ‚ä½œç”¨ã€‚åœ¨ç¼ºæ°§æ¢å¤é˜¶æ®µï¼Œå†…æºæ€§è…ºè‹·ä½œä¸ºATPåˆæˆçš„å‰ä½“,在腺苷激酶(AK)的催化下å¯å†ç”ŸæˆATPï¼Œä»¥å»¶é•¿ç»†èƒžçš„ç”Ÿå˜æ—¶é—´ã€‚è…ºè‹·æœ‰æ‰©å¼ å† çŠ¶åŠ¨è„‰è¡€ç®¡å’Œå‡ä½Žå¿ƒè‚Œæ”¶ç¼©åŠ›çš„ä½œç”¨ã€‚ä¸´åºŠä¸Šé€‚ç”¨äºŽæ²»ç–—å¿ƒç»žç—›ã€é«˜è¡€åŽ‹ã€è„‘血管障ç¢ã€ä¸é£ŽåŽé—ç—‡ã€è¿›è¡Œæ€§è‚ŒèŽç¼©ç—‡ç‰ã€‚陿³¨ç”¨äºŽæ²»ç–—室上性心动过速åŠ201Tl心肌显åƒã€‚ |
| A6218 | MACKLIN | 腺苷 | 99%生物技术级 | 32元/5g; 85元/25g; 210元/100g; 562元/500g; 1786元/2.5kg; | 咨询 |
储å˜ï¼š2~8°C 状æ€ï¼šç™½è‰²ç²‰æœ«æˆ–晶体 |
| A0152 | TCI | Adenosine | >99.0%(T)(HPLC) | 230元/5G; 670元/25G; 2150元/100G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 纯度/åˆ†æžæ–¹æ³• | >99.0%(T)(HPLC) | | 分åå¼/分åé‡ | C10H13N5O4 = 267.25 | | 外观与形状(20℃) | 固体 | | 储å˜åœ¨æƒ°æ€§æ°”体下 | å˜æ”¾äºŽæƒ°æ€§æ°”ä½“ä¹‹ä¸ | | 应é¿å…的情况 | 空气 | | Reaxys-RN | 93029 | | PubChem物质ID | 87561839 | | SDBS (AIST Spectral DB) | 828 | | Merck Index (14) | 153 | | MDLç¼–å· | MFCD00005752 |
æŠ€æœ¯è§„æ ¼ | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 99.0 area% | | Purity(Nonaqueous Titration) | min. 99.0 % | | Specific rotation [a]20/D | -69.0 to -72.0 deg(C=2, NaOH sol.(5%)) | | Lambda max. | 256.0 to 261.0 nm(0.1mol/L HCl) | | abs-ratio(a/b) | 0.81 to 0.88(E250/E260) | | abs-ratio(2a/2b) | 0.19 to 0.24(E280/E260) | | Solubility in hot Water | almost transparency |
物性(å‚考值) | 熔点 | 235 ℃ | | 比旋光度 [α]D | -70° (C=2,NaOH sol.(5%)) |
相关法规 |
| 132283 | J&K | Adenosine | 99% | 90元/5G; 266元/25G; 675元/100G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | 熔点 | 234-236 | | MDLç¼–ç | MFCD00005752 | | Beilstein | 93029 | | EINECS ç¼–å· | 200-389-9 | | å˜å‚¨æ¡ä»¶ | Store at 2-8℃ |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | æç¤ºè¯ | Warning | | å±é™©è¯´æ˜Ž | H315 H319 H335 | | 防范说明 | P261 P271 P280 | | WGK | 2 | | RTECS | AU7175000 | | TSCA | 是 |
|
| 934909 | J&K | Adenosine | 99%, 腺苷脱氢酶底物 | 71元/5G; 128元/25G; 290元/100G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | 熔点 | 234-236 | | MDLç¼–ç | MFCD00005752 | | Beilstein | 93029 | | EINECS ç¼–å· | 200-389-9 | | å˜å‚¨æ¡ä»¶ | Store at 2-8℃ |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | å±é™©è¯´æ˜Ž | H315 H319 H335 | | 防范说明 | P261 P271 P280 | | WGK | 2 | | RTECS | AU7175000 | | TSCA | 是 |
|
| 921649 | J&K | Adenosine | 有效å«é‡â‰¥90%, 坿º¯æºè‡³ä¸æ£€é™¢æ ‡å‡†å“ | 171å…ƒ/20MG; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | MDLç¼–ç | MFCD00005752 |
|
| A10781 | Alfa Aesar | Adenosine | 99% | 683元/10g; 2261元/50g; 10061元/250g; | 咨询 |
应用 Adenosine serves as a nucleotide. It also plays an important role in the regulation of blood flow to various organs through vasodilation. It is actively involved in biochemical processes, such as energy transfer as adenosine triphosphate and adenosine diphosphate. Further, it is used in medication specifically as an antiarrhythmic agent to treat a number of supraventricular tachycardia. It is used to promote thickening of hair for people with thinning hair. 备注 Store in a cool place. Incompatible with strong oxidizing agents. åŸºæœ¬ä¿¡æ¯ MDL MFCD00005752 EINECS 200-389-9 分åå¼ C10H13N5O4 分åé‡ 267.25 熔点 234-237° çµæ•度 Keep Cold. å½¢æ€ Powder 溶解性 Soluble in water, ammonium hydroxide and dimethyl sulfoxide. Insoluble in ethanol. Beilstein 93029 Merck 14,153 å®‰å…¨ä¿¡æ¯ RTECS AU7175000 TSCA 是 |
| A9251 | Sigma-Aldrich | Adenosine | ≥99% | 268.92å…ƒ/1 G; 496.35å…ƒ/5 G; 1374.74å…ƒ/25 G; 3573.78å…ƒ/100 G; | 咨询 |
产å“说明 一般æè¿° 在细胞外空间,ecto-5′-æ ¸è‹·é…¸é…¶(CD73)脱磷酸化三磷酸腺苷(ATP)而产生腺苷。腺苷有四个å—体,分别是A1Rã€A2ARã€A2BRå’ŒA3R。腺苷在æˆéª¨åˆ†åŒ–ä¸èµ·ç€å…³é”®ä½œç”¨ã€‚A1Rè¯±å¯¼ç ´éª¨ç»†èƒžåˆ†åŒ–ï¼ŒA2AR诱导æˆéª¨ç»†èƒžåˆ†åŒ–。 应用 腺苷已å¯ç”¨äºŽï¼š - 作为胚胎型培养基 体外 æˆéª¨åˆ†åŒ–的补充物
- 以3-(4,5-二甲基噻唑-2-酰基)-2,5-二苯基四唑溴化铵(MTT法)å’Œ 3H-胸苷掺入法检测其对多è¯è€è¯èƒ¶è´¨æ¯ç»†èƒžç˜¤å¹²ç»†èƒž(GSCs)的细胞增殖的影å“,并作为高效液相色谱(HPLC)çš„æ ‡å‡†å“。
- 作为胶原酶溶液ä¸çš„ä¸€ç§æˆåˆ†ï¼Œç”¨äºŽèƒ¶åŽŸé…¶æ¶ˆåŒ–å°é¼ 脂肪组织。
包装 1, 5, 25, 100 g in poly bottle 生化/生ç†ä½œç”¨ 腺苷å—ä½“å¤„çš„å†…æºæ€§ç¥žç»é€’è´¨ã€‚å¿ƒè‚Œä¿æŠ¤ä½œç”¨å¯èƒ½ä¸Ž A1 腺苷å—体的激活有关。通过 A2 腺苷å—体å¯ä»‹å¯¼è…ºè‹·çš„æŠ—è¡€å°æ¿å’ŒæŠ—炎作用。相比之下,腺苷在哮喘和慢性阻塞性肺部疾病 (COPD) ä¸èµ·ä¿ƒç‚Žä»‹è´¨ä½œç”¨ã€‚ 特点和优势 该化åˆç‰©æ”¶å½•于 å—体信å·å’Œä¿¡å·è½¬å¯¼æ‰‹å†Œçš„《腺苷酸环化酶和 磷酸肌醇激酶》 页é¢ã€‚è¦æµè§ˆå…¶ä»–手册页é¢ï¼Œè¯·å•击æ¤å¤„。 该化åˆç‰©æ˜¯çŽ¯æ ¸è‹·é…¸ç ”ç©¶çš„æŽ¨è产å“。点击æ¤å¤„æŸ¥çœ‹æ›´å¤šç‰¹è‰²çŽ¯æ ¸è‹·é…¸äº§å“。在sigma.com/discover-bsm 上了解有关生物活性å°åˆ†ååœ¨å…¶ä»–ç ”ç©¶é¢†åŸŸçš„æ›´å¤šä¿¡æ¯ã€‚ åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 93029 | | EC å· | 200-389-9 | | MDLç¼–å· | MFCD00005752 | | eCl@ss | 32160413 | | PubChem化å¦ç‰©è´¨ç¼–å· | 24277685 | | NACRES | NA.77 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 200 | | 测定 | ≥99% | | mp | 234-236 ℃ (lit.) | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O | | InChI | 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 | | InChI key | OIRDTQYFTABQOQ-KQYNXXCUSA-N | | Gene Information | human ... ADA(100), ADORA1(134), ADORA2A(135), ADORA2B(136), ADORA3(140), ERBB2(2064), ERBB4(2066) rat ... Adcy2(81636), Adora1(29290), Adora2a(25369), Adora3(25370) |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type N95 (US) |
|
| A4036 | Sigma-Aldrich | Adenosine | suitable for cell culture, BioReagent | 497.2元/5 g; 1638.5元/25 g; | 咨询 |
产å“说明 一般æè¿° æ ¸è‹·(腺苷)由嘌呤(腺嘌呤)和糖(æ ¸ç³–)组æˆã€‚å› æ¤ï¼Œå®ƒä¹Ÿç§°ä¸ºè…ºå˜Œå‘¤-D-æ ¸ç³–ã€‚è…ºè‹·æ˜¯å½¢æˆæ ¸è‹·é…¸çš„é‡è¦åˆ†åï¼Œè€Œæ ¸è‹·é…¸æ˜¯å½¢æˆ DNA å’Œ RNA æ ¸é…¸çš„ä¸€éƒ¨åˆ†ã€‚æ ¸è‹·é…¸åŒ…æ‹¬ï¼šå•磷酸腺苷,二磷酸腺苷和三磷酸腺苷。 应用 腺苷用作DMEM(æœæ°æ”¹è‰¯Eagle培养基)ä¸çš„补充剂,用于: - 评估物ç§é—´ä½“ç»†èƒžæ ¸è½¬ç§»(iSCNT)分化的胚泡生长情况
- ç»´æŒ CGR8 Es(ç”Ÿæ®–ç³»æ„Ÿå—æ€ç»†èƒžç³»)细胞的状æ€è´¨ç²’转染和克隆胚胎干细胞
- 质粒转染和克隆胚胎干细胞
包装 5, 25 g in poly bottle 生化/生ç†ä½œç”¨ 腺苷å—ä½“å¤„çš„å†…æºæ€§ç¥žç»é€’è´¨ã€‚å¿ƒè‚Œä¿æŠ¤ä½œç”¨å¯èƒ½ä¸Ž A1 腺苷å—体的激活有关。通过 A2 腺苷å—体å¯ä»‹å¯¼è…ºè‹·çš„æŠ—è¡€å°æ¿å’ŒæŠ—炎作用。相比之下,腺苷在哮喘和慢性阻塞性肺部疾病 (COPD) ä¸èµ·ä¿ƒç‚Žä»‹è´¨ä½œç”¨ã€‚ 组织æŸä¼¤ï¼Œç¼ºè¡€å’Œå¼‚常细胞增殖刺激腺苷的释放。心è„ã€å¤§è„‘和骨骼肌ç‰å™¨å®˜ä¸æ°§æ°”和能é‡å‡å°‘ï¼Œèƒ½å¼•èµ·è¡€ç®¡èˆ’å¼ ã€‚è…ºè‹·æœ‰åŠ©äºŽæŠµæŠ—è¡€ç®¡èˆ’å¼ çš„å½±å“。 它通过G蛋白å¶è”å—体呿Œ¥ä½œç”¨ã€‚腺苷还å¯å‡å°‘神ç»é€’质释放和细胞代谢。 åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 93029 | | EC å· | 200-389-9 | | MDLç¼–å· | MFCD00005752 | | eCl@ss | 32160413 | | PubChem化å¦ç‰©è´¨ç¼–å· | 24890739 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 200 | | ç”Ÿç‰©æ¥æº | synthetic (organic) | | 产å“线 | BioReagent | | 测定 | ≥99% (HPLC) | | å½¢å¼ | powder | | technique(s) | cell culture | mammalian: suitable | | mp | 234-236 ℃ (lit.) | | 溶解性 | 1 M NH4OH: 50 mg/mL, clear, colorless | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O | | InChI | 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 | | InChI key | OIRDTQYFTABQOQ-KQYNXXCUSA-N | | Gene Information | human ... ADA(100), ADORA1(134), ADORA2A(135), ADORA2B(136), ADORA3(140), ERBB2(2064), ERBB4(2066) rat ... Adcy2(81636), Adora1(29290), Adora2a(25369), Adora3(25370) |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type N95 (US) |
|
| 01890 | Sigma-Aldrich | Adenosine | | 598.14元/5G; 1526.64元/25G; 4450.9元/100G; | 咨询 |
产å“说明 生化/生ç†ä½œç”¨ 腺苷å—ä½“å¤„çš„å†…æºæ€§ç¥žç»é€’è´¨ã€‚å¿ƒè‚Œä¿æŠ¤ä½œç”¨å¯èƒ½ä¸Ž A1 腺苷å—体的激活有关。通过 A2 腺苷å—体å¯ä»‹å¯¼è…ºè‹·çš„æŠ—è¡€å°æ¿å’ŒæŠ—炎作用。相比之下,腺苷在哮喘和慢性阻塞性肺部疾病 (COPD) ä¸èµ·ä¿ƒç‚Žä»‹è´¨ä½œç”¨ã€‚ 其他说明 用于测定腺苷脱氨酶的底物 åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 93029 | | EC å· | 200-389-9 | | MDLç¼–å· | MFCD00005752 | | eCl@ss | 32160413 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329747369 | | NACRES | NA.77 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 200 | | å½¢å¼ | powder | | 旋光性 | [α]20/D −70±3°, c = 2% in 5% NaOH | | ç¼çƒ§æ®‹æ¸£ | ≤0.1% (as SO4) | | mp | 234-236 ℃ (lit.) | | ç—•é‡é˜³ç¦»å | Ca: ≤10 mg/kg Cd: ≤5 mg/kg Co: ≤5 mg/kg Cr: ≤5 mg/kg Cu: ≤5 mg/kg Fe: ≤5 mg/kg Mg: ≤20 mg/kg Mn: ≤5 mg/kg Ni: ≤5 mg/kg Pb: ≤5 mg/kg Zn: ≤5 mg/kg | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O | | InChI | 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 | | InChI key | OIRDTQYFTABQOQ-KQYNXXCUSA-N | | Gene Information | human ... ADORA1(134), ADORA2A(135), ADORA2B(136), ADORA3(140) |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type N95 (US) |
|
| PHR1138 | Supelco | Adenosine | Pharmaceutical Secondary Standard; Certified Reference Material | 1359.83元/1 G; | 咨询 |
产å“说明 一般æè¿° 腺苷是一ç§å˜Œå‘¤æ ¸è‹·ï¼ŒåŒæ—¶ä¹Ÿæ˜¯RNA和许多其他生物分å(å¦‚ä¸‰ç£·é…¸è…ºè‹·å’ŒçƒŸé…°èƒºè…ºå˜Œå‘¤äºŒæ ¸è‹·é…¸)的结构å•元。在细胞外空间,ecto-′-æ ¸è‹·é…¸é…¶ (CD73) 使三磷酸腺苷 (ATP) 脱磷酸化而产生腺苷。腺苷有四个å—体,分别是A1Rã€A2ARã€A2BRå’ŒA3R。腺苷在æˆéª¨åˆ†åŒ–ä¸èµ·ç€å…³é”®ä½œç”¨ã€‚A1Rè¯±å¯¼ç ´éª¨ç»†èƒžåˆ†åŒ–ï¼ŒA2AR诱导æˆéª¨ç»†èƒžåˆ†åŒ–。 ç”¨äºŽè´¨é‡æŽ§åˆ¶çš„åˆ¶è¯äºŒçº§æ ‡å‡†å“,为制è¯å®žéªŒå®¤å’Œåˆ¶é€ å•†åˆ¶å¤‡å†…éƒ¨å·¥ä½œæ ‡å‡†å“æä¾›äº†ä¸€ç§æ–¹ä¾¿ã€é«˜æ€§ä»·æ¯”的替代方案。 应用 腺苷å¯ç”¨ä½œè¯ç‰©å‚è€ƒæ ‡å‡†å“,用于通过高效液相色谱技术和毛细管电泳对输液溶液ä¸çš„分æžç‰©è¿›è¡Œå®šé‡ã€‚ è¿™äº›äºŒçº§æ ‡å‡†å“æ˜¯åˆæ ¼çš„è®¤è¯æ ‡å‡†ç‰©è´¨(CRM)。它们适用于多ç§åˆ†æžåº”用,包括但ä¸é™äºŽè¯ç‰©é‡Šæ”¾æµ‹è¯•ã€è¯ç‰©çš„定性和定é‡åˆ†æžæ–¹æ³•å¼€å‘ã€é£Ÿå“å’Œé¥®æ–™è´¨é‡æŽ§åˆ¶æ£€æµ‹ä»¥åŠå…¶ä»–æ ¡å‡†éœ€æ±‚ã€‚ 生化/生ç†ä½œç”¨ 腺苷å—ä½“å¤„çš„å†…æºæ€§ç¥žç»é€’è´¨ã€‚å¿ƒè‚Œä¿æŠ¤ä½œç”¨å¯èƒ½ä¸Ž A1 腺苷å—体的激活有关。通过 A2 腺苷å—体å¯ä»‹å¯¼è…ºè‹·çš„æŠ—è¡€å°æ¿å’ŒæŠ—炎作用。相比之下,腺苷在哮喘和慢性阻塞性肺部疾病 (COPD) ä¸èµ·ä¿ƒç‚Žä»‹è´¨ä½œç”¨ã€‚ 分æžè¯´æ˜Ž è¿™äº›äºŒçº§æ ‡å‡†å“å¯è¿½æº¯è‡³USPã€EP(PhEur)å’ŒBPä¸€çº§æ ‡å‡†å“。 其他说明 本认è¯å‚è€ƒææ–™æ˜¯æ ¹æ®ISO 17034å’ŒISO/IEC 17025生产和认è¯çš„。所有关于客户关系管ç†çš„ä¿¡æ¯éƒ½å¯ä»¥åœ¨åˆ†æžè¯ä¹¦ä¸Šæ‰¾åˆ°ã€‚ 附注 è¦æŸ¥çœ‹è¯¥ææ–™çš„æ£€éªŒæŠ¥å‘Šç¤ºä¾‹ï¼Œè¯·åœ¨ä¸‹é¢çš„æ’æ§½ä¸è¾“å…¥ LRAA7134ã€‚è¿™åªæ˜¯ä¸€ä¸ªç¤ºä¾‹è¯ä¹¦ï¼Œå¯èƒ½ä¸æ˜¯æ‚¨æ”¶åˆ°çš„æ‰¹æ¬¡ã€‚ åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 93029 | | EC å· | 200-389-9 | | MDLç¼–å· | MFCD00005752 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329823158 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 300 | | ç‰çº§ | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | mp | 234-236 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | è¯å…¸å¯è¿½æº¯æ€§ | traceable to PhEur A0230200 traceable to USP 1012123 | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O | | InChI | 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 | | InChI key | OIRDTQYFTABQOQ-KQYNXXCUSA-N | | Gene Information | human ... ADORA1(134), ADORA2A(135), ADORA2B(136), ADORA3(140) |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| A0230200 | | Adenosine | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生ç†ä½œç”¨ 腺苷å—ä½“å¤„çš„å†…æºæ€§ç¥žç»é€’è´¨ã€‚å¿ƒè‚Œä¿æŠ¤ä½œç”¨å¯èƒ½ä¸Ž A1 腺苷å—体的激活有关。通过 A2 腺苷å—体å¯ä»‹å¯¼è…ºè‹·çš„æŠ—è¡€å°æ¿å’ŒæŠ—炎作用。相比之下,腺苷在哮喘和慢性阻塞性肺部疾病 (COPD) ä¸èµ·ä¿ƒç‚Žä»‹è´¨ä½œç”¨ã€‚ 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. æ³¨æ„ Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 93029 | | MDLç¼–å· | MFCD00005752 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329770589 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | mp | 234-236 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O | | InChI | 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 | | InChI key | OIRDTQYFTABQOQ-KQYNXXCUSA-N | | Gene Information | human ... ADORA1(134), ADORA2A(135), ADORA2B(136), ADORA3(140) |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| V900417 | Sigma-Aldrich | Adenosine | Vetec™, reagent grade, 98% | 248.8å…ƒ/25 G; 718.78å…ƒ/100 G; | 咨询 |
产å“说明 包装 25, 100 g in poly bottle 生化/生ç†ä½œç”¨ 腺苷å—ä½“å¤„çš„å†…æºæ€§ç¥žç»é€’è´¨ã€‚å¿ƒè‚Œä¿æŠ¤ä½œç”¨å¯èƒ½ä¸Ž A1 腺苷å—体的激活有关。通过 A2 腺苷å—体å¯ä»‹å¯¼è…ºè‹·çš„æŠ—è¡€å°æ¿å’ŒæŠ—炎作用。相比之下,腺苷在哮喘和慢性阻塞性肺部疾病 (COPD) ä¸èµ·ä¿ƒç‚Žä»‹è´¨ä½œç”¨ã€‚ æ³•å¾‹ä¿¡æ¯ Vetec is a trademark of sigma-aldrich International GmbH åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 93029 | | EC å· | 200-389-9 | | MDLç¼–å· | MFCD00005752 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329829826 |
äº§å“æ€§è´¨ | ç‰çº§ | reagent grade | | 产å“线 | Vetec™ | | 测定 | 98% | | mp | 234-236 ℃ (lit.) | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O | | InChI | 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 | | InChI key | OIRDTQYFTABQOQ-KQYNXXCUSA-N | | Gene Information | human ... ADORA1(134), ADORA2A(135), ADORA2B(136), ADORA3(140) |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1012123 | USP | Adenosine | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Ph 生化/生ç†ä½œç”¨ 腺苷å—ä½“å¤„çš„å†…æºæ€§ç¥žç»é€’è´¨ã€‚å¿ƒè‚Œä¿æŠ¤ä½œç”¨å¯èƒ½ä¸Ž A1 腺苷å—体的激活有关。通过 A2 腺苷å—体å¯ä»‹å¯¼è…ºè‹·çš„æŠ—è¡€å°æ¿å’ŒæŠ—炎作用。相比之下,腺苷在哮喘和慢性阻塞性肺部疾病 (COPD) ä¸èµ·ä¿ƒç‚Žä»‹è´¨ä½œç”¨ã€‚ 分æžè¯´æ˜Ž These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 93029 | | MDLç¼–å· | MFCD00005752 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329748939 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | USP | | mp | 234-236 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | SMILES string | Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O | | InChI | 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 | | InChI key | OIRDTQYFTABQOQ-KQYNXXCUSA-N | | Gene Information | human ... ADORA1(134), ADORA2A(135), ADORA2B(136), ADORA3(140) |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHL80977 | | Adenosine | phyproof® Reference Substance | 3048.57å…ƒ/100 MG; | 咨询 |
产å“说明 一般æè¿° This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate. Produced by PhytoLab GmbH & Co. KG 生化/生ç†ä½œç”¨ 腺苷å—ä½“å¤„çš„å†…æºæ€§ç¥žç»é€’è´¨ã€‚å¿ƒè‚Œä¿æŠ¤ä½œç”¨å¯èƒ½ä¸Ž A1 腺苷å—体的激活有关。通过 A2 腺苷å—体å¯ä»‹å¯¼è…ºè‹·çš„æŠ—è¡€å°æ¿å’ŒæŠ—炎作用。相比之下,腺苷在哮喘和慢性阻塞性肺部疾病 (COPD) ä¸èµ·ä¿ƒç‚Žä»‹è´¨ä½œç”¨ã€‚ æ³•å¾‹ä¿¡æ¯ phyproof is a registered trademark of PhytoLab GmbH & Co. KG åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | Beilstein | 93029 | | MDLç¼–å· | MFCD00005752 |
äº§å“æ€§è´¨ | ç‰çº§ | primary reference standard | | 产å“线 | phyproof® Reference Substance | | 测定 | ≥98.0% (HPLC) | | å½¢å¼ | solid | | manufacturer/tradename | PhytoLab | | mp | 234-236 ℃ (lit.) | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O | | InChI | 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 | | InChI key | OIRDTQYFTABQOQ-KQYNXXCUSA-N | | Gene Information | human ... ADORA1(134), ADORA2A(135), ADORA2B(136), ADORA3(140) |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 365735 | Amethyst | Adenosine | 99%, 试剂级 | 51元/5G; 67元/25G; 135元/100G; 509元/500G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 分åå¼ | C10H13N5O4 | | 分åé‡ | 267.24 | | 熔点 | 234-236 | | MDLç¼–ç | MFCD00005752 | | Beilstein | 93029 | | EINECS ç¼–å· | 200-389-9 | | å˜å‚¨æ¡ä»¶ | Store at 2-8℃ |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | æç¤ºè¯ | Warning | | å±é™©è¯´æ˜Ž | H315 H319 H335 | | 防范说明 | P261 P271 P280 | | WGK | 2 | | RTECS | AU7175000 | | TSCA | 是 |
|
| 093333 | Fluorochem | Adenosine | 99% | 220元/5g; 352元/25g; 880元/100g; 1738元/250g; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | CAS Number | 58-61-7 | | MDL Number | MFCD00005752 | | Melting Point | 233-238℃ |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | å±é™©æ€§è¯´æ˜Ž | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing . P264: Wash hands thoroughly after handling. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.. P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see relevant procedures. on this label). P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to in accordance with local regulation .
|
|